Tumor "nemesis": DC-CIK cell immunotherapy

Nov 06,2023

DC-CIK biological cell immunotherapy is a DC-CIK autologous cell therapy technology, which is a research breakthrough found by scientists in the field of cancer treatment from the rapid development of cytology and immunology.

CIK cells write into CSCO guidelines into epoch-making milestone

Congratulations to Professor Qi on his deeds and his national cell patented technology, which are called "Red Wall Publication" and "Leader Magazine" for the National Day Special Issue of "Chinese Talents" (2023.9.16, 2023, No. 18, Total 798)

Related dynamics

Clinical study of innovative healthy human allogeneic immune cells in the treatment of advanced cancer

Here is the placeholder text

Tumor postoperative immune cells, rebuild the immune system, can prevent cancer metastasis and recurrence!

Here is the placeholder text

Quick Navigation

Home Page

Personal Profile

Personal presentation

Honor

Case

Media coverage

Kunsheng Biological Team

online message

SEO Tags

京ICP备10002622号

Technical Support:China Enterprise Power 300.cn